Softwr

Healthcare · head to head

Allscripts TouchWorks vs Therapixel

Allscripts TouchWorks logo

Allscripts TouchWorks

Healthcare

Cloud-based EHR and practice management for ambulatory care

From
$200/month
Rated
-
Full reviewWebsite
Therapixel logo

Therapixel

Healthcare

French mammography AI with FDA clearances for 2D and tomosynthesis breast screening

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Allscripts TouchWorks allscripts moved its products to the Veradigm brand in 2022, so the Allscripts name is retired; Therapixel european and American regulatory positions were established under different regimes, and under the EU Medical Device Regulation this class of diagnostic AI faces a higher classification and notified body scrutiny, so European buyers must verify the current MDR certificate and expiry rather than relying on a legacy CE reference.
  • They diverge on capability: Allscripts TouchWorks covers Electronic Health Records, Therapixel covers MammoScreen 2D.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Allscripts TouchWorks and Therapixel actually diverge.

Attributes where Allscripts TouchWorks and Therapixel differ
AttributeAllscripts TouchWorksTherapixel
Starting price$200/monthOn request
Pricing modelsubscriptionquote
PlatformsWeb, MobileWeb
Founded1986Unknown

Identical on both: free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Allscripts TouchWorks

  • Electronic Health Records
  • Practice Management
  • ePrescribing
  • Patient Portal
  • Scheduling
  • Revenue Cycle Management
  • HL7
  • FHIR

Only in Therapixel

  • MammoScreen 2D
  • MammoScreen DBT
  • One to ten suspicion score
  • Summary report
  • Workstation and PACS delivery
  • Reading workflow configurations

What people use each for

The jobs each tool is most often brought in to do.

Allscripts TouchWorks

  • Patient Carenot Therapixel
  • Medical Recordsnot Therapixel
  • Practice Managementnot Therapixel
  • Telehealthnot Therapixel

Therapixel

  • A European breast screening programme running mandatory double reading that wants to evaluate AI as a concurrent or second reader within what national guidance permitsnot Allscripts TouchWorks
  • An American breast centre that has moved to tomosynthesis and needs reading support on DBT specifically, which Therapixel holds a clearance fornot Allscripts TouchWorks
  • A screening service wanting a graded suspicion score rather than a binary flag so readers can calibrate their own thresholdnot Allscripts TouchWorks
  • A radiology group evaluating multiple mammography AI vendors head to head on their own historic case set before committingnot Allscripts TouchWorks

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Allscripts TouchWorks

  • Allscripts moved its products to the Veradigm brand in 2022, so the Allscripts name is retired
  • Pricing is not published
  • TouchWorks is not named on the Veradigm site, so whether it survives as a distinct product cannot be confirmed from the vendor

Therapixel

  • European and American regulatory positions were established under different regimes, and under the EU Medical Device Regulation this class of diagnostic AI faces a higher classification and notified body scrutiny, so European buyers must verify the current MDR certificate and expiry rather than relying on a legacy CE reference.
  • MammoScreen does mammography only, so a hospital wanting AI across head CT, chest and breast needs several vendors and several PACS integrations, or an orchestration layer bought from someone else.
  • Therapixel is a small French company competing against Hologic and iCAD, which have incumbency inside the mammography reading workstation, so integration into an American breast centre is more work than it is for the workstation vendor own AI.
  • Detection performance is sensitive to the mammography unit vendor and acquisition protocol, so published results do not transfer between estates and each site needs local validation it must fund itself.
  • Whether AI can substitute for one of two human readers is a national workforce and liability question, not a product capability, so the labour saving that justifies the purchase in one country is not permitted in another.

Pricing, plan by plan

Allscripts TouchWorks

$200/month

No published plan breakdown. See the Allscripts TouchWorks review.

Therapixel

On request
  • MammoScreen$undefined/year
    • Priced per examination or by annual screening volume
    • 2D and tomosynthesis licensed by the versions cleared for each
    • Cloud or on premises deployment quoted differently

Which should you pick?

Choose Allscripts TouchWorks if

  • You need electronic health records.
  • You work on Web, Mobile.
  • You also want practice management.
Allscripts TouchWorks review

Choose Therapixel if

  • You need mammoscreen 2d.
  • You also want mammoscreen dbt.
Therapixel review

Questions people ask

Is Allscripts TouchWorks or Therapixel better?
Neither clearly leads. Allscripts TouchWorks starts at $200/month and Therapixel at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Allscripts TouchWorks or Therapixel?
Allscripts TouchWorks starts at $200/month and Therapixel at On request.
Does Allscripts TouchWorks or Therapixel run on more platforms?
Allscripts TouchWorks runs on Web, Mobile. Therapixel runs on Web.
What is Allscripts TouchWorks best used for?
Allscripts TouchWorks is most often used for patient care, medical records, practice management, telehealth. Of those, patient care and medical records are not what Therapixel is typically brought in for.
What can Allscripts TouchWorks do that Therapixel cannot?
Allscripts TouchWorks covers Electronic Health Records, Practice Management, ePrescribing, Patient Portal. Therapixel covers MammoScreen 2D, MammoScreen DBT, One to ten suspicion score, Summary report.

Answered from the vendors’ own pages

Allscripts TouchWorks: How is Allscripts TouchWorks priced?

Pricing is not published on Veradigm's website. Costs are customized based on practice size, feature requirements, and deployment preferences.

Source
Therapixel: Is MammoScreen FDA cleared?

Yes. It holds 510(k) clearance K192854 for two dimensional mammography from July 2020, a November 2021 clearance for digital breast tomosynthesis, and two further clearances in October 2024 for later versions.

Allscripts TouchWorks: How do I get pricing and request a demo for TouchWorks?

Contact a Veradigm Account Executive or use the 'Get Demo' button on their website to discuss pricing, trial programs, and implementation.

Source
Therapixel: Is it CE marked?

Yes, but European buyers should ask specifically for the current certificate under the Medical Device Regulation and its expiry date, because this class of diagnostic AI moved to a higher classification under MDR.

Allscripts TouchWorks: What market segments does Veradigm serve?

Veradigm serves healthcare providers with EHR and practice management solutions, life sciences companies, and health plans/payers with risk adjustment and quality analytics.

Source
Therapixel: What does the one to ten score mean?

It is a graded suspicion score per finding and per study, designed to be integrated alongside a radiologist BI-RADS assessment rather than treated as a positive or negative result.

Therapixel: Does it cover anything besides mammography?

No. It is a mammography product only, including tomosynthesis. Other body regions need a different vendor.

Share

Related pages

More on Allscripts TouchWorks

More on Therapixel

Keep looking

Other head to heads